New Study Results on Pain and Patients with Neurofibromatosis Type 1
Frank Buono PhD, from the Department of Psychiatry at Yale School of Medicine and longtime member and supporter of NF…
Read MoreFrank Buono PhD, from the Department of Psychiatry at Yale School of Medicine and longtime member and supporter of NF…
Read MoreMassachusetts General Hospital is looking for adults with NF1, NF2, or Schwannomatosis to participate in a research study to enhance…
Read MoreIn February, NF Midwest staff and volunteers will once descend on Washington DC along with other NF organizations to ask…
Read MoreIf you’ve been paying any attention to NF research in the last several years you’ll have noticed that in clinical…
Read MoreThis past February, NF Midwest brought volunteers to Washington DC to once again advocate for federal dollars for neurofibromatosis type…
Read MoreAre you the parent/caregiver of a child with neurofibromatosis type 1 (NF1) between the ages of 3-18 years? The MIND…
Read MoreThe efforts of our community, our donors, and the advocacy of NF Midwest (and other NF organizations) all worked together…
Read MoreThe Education and Brain Sciences Research lab at Vanderbilt University is seeking participants for a new research study! The purpose…
Read MoreNF Midwest, in collaboration with NF Northeast, has awarded Dr. Vijaya Ramesh from Massachusetts General Hospital, a grant for research in neurofibromatosis…
Read MoreIn February AstraZeneca and Merck announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.